We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 932 results
  1. Important oncogenic and immunogenic roles of SPP1 and CSF1 in hepatocellular carcinoma

    The treatment and prognosis of liver cancer remain the focus of medical research. Studies have shown that SPP1 and CSF1 play important roles in cell...

    Tianxin **ang, Na Cheng, ... ** Zeng in Medical Oncology
    Article Open access 25 April 2023
  2. Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment

    The macrophage colony-stimulating factor 1 (CSF1) is a chemokine essential for the survival, proliferation, and differentiation of mononuclear...

    Maria del Mar Maldonado, Jeffrey Schlom, Duane H. Hamilton in Cancer Immunology, Immunotherapy
    Article Open access 28 July 2023
  3. Diagnostic utility of CSF1 immunohistochemistry in tenosynovial giant cell tumor for differentiating from giant cell-rich tumors and tumor-like lesions of bone and soft tissue

    Background

    Tenosynovial giant cell tumor (TSGCT) is a benign fibrohistiocytic tumor that affects the synovium of joints, bursa, and tendon sheaths and...

    Shintaro Sugita, Tomoko Takenami, ... Tadashi Hasegawa in Diagnostic Pathology
    Article Open access 01 November 2022
  4. Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130

    Macrophages are increased in human benign prostatic hyperplasia and prostate cancer. We generate a Pb-Csf1 mouse model with prostate-specific...

    Oh-Joon Kwon, Boyu Zhang, ... Li **n in Oncogene
    Article 08 January 2022
  5. Plexiform fibrohistiocytic tumor: a clinicopathological and immunohistochemical study of 39 tumors, with evidence for a CSF1-producing “null cell” population

    Plexiform fibrohistiocytic tumor (PFHT) is a mesenchymal tumor of intermediate malignancy, typically occurring in the superficial soft tissues of...

    Judith Jebastin Thangaiah, Nooshin K. Dashti, ... Andrew L. Folpe in Virchows Archiv
    Article 07 September 2022
  6. miR-1968-5p is involved in the pathogenesis of lupus nephritis of NZBWF1 mice by targeting csf1

    Objective

    Lupus nephritis is one of the most common and severe systemic lupus erythematosus complications. However, the pathogenesis of lupus...

    Shipeng Li, **a Wang, ... Caifeng Li in Clinical and Experimental Nephrology
    Article 06 July 2021
  7. Interleukin-32γ promotes macrophage-mediated chemoresistance by inducing CSF1-dependent M2 macrophage polarization in multiple myeloma

    Macrophages (MΦs) are an abundant component in the multiple myeloma (MM) environment and contribute to MM drug resistance. We previously showed that...

    Haimeng Yan, Donghua He, ... Zhen Cai in Cancer Immunology, Immunotherapy
    Article 26 July 2022
  8. CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis

    Epigenetic alterations play an important role in tumor progression of diffuse large B-cell lymphoma (DLBCL). However, the biological relevance of...

    Yao-Hui Huang, Kun Cai, ... Wei-Li Zhao in Signal Transduction and Targeted Therapy
    Article Open access 11 January 2021
  9. MiR-423-5p may regulate ovarian response to ovulation induction via CSF1

    Background

    We have previously shown that hsa-miR-423-5p expression in ovarian granulosa cells is decreased in high ovarian response populations. The...

    Article Open access 07 April 2020
  10. CSF1R as a Therapeutic Target in Bone Diseases: Obvious but Not so Simple

    Purpose of Review

    The purpose of the review is to summarize the expression and function of CSF1R and its ligands in bone homeostasis and constraints...

    David A. Hume, Lena Batoon, ... Katharine M. Irvine in Current Osteoporosis Reports
    Article Open access 05 October 2022
  11. CSF1R inhibition with PLX5622 affects multiple immune cell compartments and induces tissue-specific metabolic effects in lean mice

    Aims/hypothesis

    Colony stimulating factor 1 (CSF1) promotes the proliferation, differentiation and survival of macrophages, which have been implicated...

    Angela J. T. Bosch, Lena Keller, ... Claudia Cavelti-Weder in Diabetologia
    Article Open access 04 October 2023
  12. Ethanol withdrawal-induced adaptations in prefrontal corticotropin releasing factor receptor 1-expressing neurons regulate anxiety and conditioned rewarding effects of ethanol

    Prefrontal circuits are thought to underlie aberrant emotion contributing to relapse in abstinence; however, the discrete cell-types and mechanisms...

    Reesha R. Patel, Sarah A. Wolfe, ... Marisa Roberto in Molecular Psychiatry
    Article Open access 06 June 2022
  13. A phase I/II study of MCS110 with BRAF/MEK inhibition in patients with melanoma after progression on BRAF/MEK inhibition

    Background: Prognosis for patients with metastatic melanoma has been improved dramatically with the development of BRAF/MEK directed therapy and...

    Elizabeth I. Buchbinder, Anita Giobbie-Hurder, Patrick A. Ott in Investigational New Drugs
    Article 25 April 2023
  14. Baricitinib ameliorates inflammatory and neuropathic pain in collagen antibody-induced arthritis mice by modulating the IL-6/JAK/STAT3 pathway and CSF-1 expression in dorsal root ganglion neurons

    Background

    Janus kinase (JAK) inhibitors, such as baricitinib, are widely used to treat rheumatoid arthritis (RA). Clinical studies show that...

    Kenta Makabe, Hiroyuki Okada, ... Taku Saito in Arthritis Research & Therapy
    Article Open access 15 June 2024
  15. Systemic interrogation of immune-oncology-related proteins in patients with locally advanced prostate cancer undergoing androgen deprivation and intensity-modulated radiotherapy

    Purpose

    The primary objective was to establish whether blood-based leucine-rich alpha-2-glycoprotein (LRG1) can predict outcomes in patients with...

    Ingrid Jenny Guldvik, Håkon Ramberg, ... Kristin Austlid Taskén in World Journal of Urology
    Article Open access 22 February 2024
  16. Stable colony-stimulating factor 1 fusion protein treatment increases hematopoietic stem cell pool and enhances their mobilisation in mice

    Background

    Prior chemotherapy and/or underlying morbidity commonly leads to poor mobilisation of hematopoietic stem cells (HSC) for transplantation in...

    Simranpreet Kaur, Anuj Sehgal, ... Allison R. Pettit in Journal of Hematology & Oncology
    Article Open access 06 January 2021
  17. Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas

    Background

    New entities in the classification of bone and soft tissue tumors have been identified by use of advanced molecular-genetic...

    J. C. Fanburg-Smith, J. D. Smith, D. J. Flemming in Skeletal Radiology
    Article 21 December 2022
  18. The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces tissue macrophage levels without affecting glucose homeostasis in mice

    Background and objectives

    Excessive adipose tissue macrophage accumulation in obesity has been implicated in mediating inflammatory responses that...

    Troy L. Merry, Anna E. S. Brooks, ... Peter R. Shepherd in International Journal of Obesity
    Article 29 March 2019
  19. Maternal mid-gestational and child cord blood immune signatures are strongly associated with offspring risk of ASD

    Epidemiological studies and work in animal models indicate that immune activation may be a risk factor for autism spectrum disorders (ASDs). We...

    **aoyu Che, Mady Hornig, ... W. Ian Lipkin in Molecular Psychiatry
    Article 05 January 2022
  20. Zishen Pill alleviates diabetes in Db/db mice via activation of PI3K/AKT pathway in the liver

    Background

    The rising global incidence of type 2 diabetes mellitus (T2DM) highlights a need for new therapies. The Zishen Pill (ZSP) is a traditional...

    You Wu, Boju Sun, ... Tonghua Liu in Chinese Medicine
    Article Open access 10 November 2022
Did you find what you were looking for? Share feedback.